z-logo
open-access-imgOpen Access
Effects of dimethyl propranolol (UM-272; SC-27761) on myocardial ischemic injury in the canine heart after temporary coronary artery occlusion.
Author(s) -
David D. Ku,
Benedict R. Lucchesi
Publication year - 1978
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.57.3.541
Subject(s) - medicine , cardiology , creatine kinase , artery , occlusion , propranolol , qrs complex , st segment , ischemia , coronary artery occlusion , myocardial ischemia , coronary occlusion , myocardial infarction , anesthesia
Myocardial ischemic injury after temporary occlusion of the left anterior descending coronary artery (LAD) for 90 min followed by reperfusion was estimated from the epicardial ST-segment elevation 15 min after occlusion (ST15m), changes in QRS complex, myocardial creatine kinase (CPK) activity and nitro-blue-tetrazolium (NBT) staining at 24 hours. At all sites exhibiting ST15m greater than 2 mV, there was a small development of epicardial Q waves after 90 min of occlusion (sigma deltaQ = 6.94 +/- 0.52 mV) and was maintained for 24 hours. Good correlations were obtained between CPK activity at 24 hours and the development of Q waves at 24 hours as well as at 60 min after reperfusion (r = 0.49; N = 56). Pretreatment with UM-272 significantly reduced the development of Q-waves (sigma deltaQ1hr = 2.23 +/- 0.75 mV) which was correlated with less CPK depletion and smaller infarct size as determined on the bais of NBT staining for myocardial tissue dehydrogenases at 24 hours. It appears, therefore, that the assessment of pathoologic Q wave development provides an accurate and early estimate of the extent of the ultimate cardiac damage due to ischemia and that pretreatment with UM-272 exerts a protective effect on the ischemic myocardium.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom